Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Honorary Senior Lecturer



daniel.munblit08 Website CV




Paediatric Research UnitQueen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus





Honorary Senior Lecturer at Inflammation, Repair and Development Section, NHLI, St Mary's Campus.

Dr Munblit graduated from a Russian State Medical University in 2003 and then been trained at the Moscow Institute of Paediatrics and Child Surgery.

Daniel accomplished his PhD research at Imperial College London in 2016. Prior to this he successfully completed MSc in Allergy programme at Imperial College London.

His main research focus is the primary prevention of allergic disease in childhood. Investigation of human colostrum and mature breast milk immune-modulatory factors in relation to maternal health, nutrition and genotype and subsequent infant outcomes in relation to susceptibility to allergy. Later he has developed a strong interest in systematic evaluation of available evidence in paediatrics and child health.

Dr. Munblit coordinated EU Horizon 2020 application (BIRTH project) in 2014. This project aimed to develop standards for human milk analysis, identify maternal genetic and environmental factors that modify milk composition, systematically review existing evidence on human milk research and conduct intervention trials in mothers aiming to modify human milk composition andthereby promote improved health outcomes in the child.

Daniel leads The Core Outcome Measures for Food Allergy (COMFA) COST Action, approved by the EU commissioners in June 2019. This project is aiming to define the scope and applicability of food allergy Core Outcome sets and develop Core Outcome sets and measurement tools for food allergy.

Dr. Munblit is a member of the European Academy of Allergy and Clinical Immunology (EAACI) Pediatric section board. He is also a member of Paediatric Allergy Education & Training Committee (PA-ETC) at EAACI and a member of Education & Training Committee at World Allergy Organization (WAO).

Dr. Munblit shares his time between London and Moscow, Russia. He is an Associate Professor at the Department of Paediatrics and Infectious Diseases at Sechenov University.

Apart from research activities, Daniel is lecturing at MSc in Paediatrics and MSc in Allergy courses and supervising students at Imperial College London and Sechenov University.



Brough HA, Kalayci O, Sediva A, et al., 2020, Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic., Pediatr Allergy Immunol

Munblit D, Perkin MR, Palmer DJ, et al., 2020, Assessment of evidence about common infant symptoms and cow’s milk allergy, Jama Pediatrics, ISSN:2168-6203

Korsunskiy I, Blyuss O, Gordukova M, et al., 2020, Expanding TREC utility in primary immunodeficiency diseases diagnosis, Frontiers in Immunology, Vol:11, ISSN:1664-3224

Blyuss O, Zaikin A, Cherepanova V, et al., 2020, Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients, British Journal of Cancer, Vol:122, ISSN:0007-0920, Pages:692-696

DunnGalvin A, Treneva M, Pampura A, et al., 2019, Quality of life associated with maternal anxiety disorder in Russian children and adolescents with food allergy, Pediatric Allergy and Immunology, Vol:31, ISSN:0905-6157, Pages:78-84

More Publications